HPLC analysis of in vivo intestinal absorption and oxidative metabolism of salicylic acid in the rat. 2016

Mónika Kuzma, and Eszter Nyúl, and Mátyás Mayer, and Emil Fischer, and Pál Perjési
Institute of Pharmaceutical Chemistry, University of Pécs, H-7624, Pécs, Rókus str. 2, Hungary.

In vivo absorption and oxidative metabolism of salicylic acid in rat small intestine was studied by luminal perfusion experiment. Perfusion through the lumen of proximal jejunum with isotonic medium containing 250 μm sodium salicylate was carried out. Absorption of salicylate was measured by a validated HPLC-DAD method which was evaluated for a number of validation characteristics (specificity, repeatability and intermediate precision, limit of detection, limit of quantification, linearity and accuracy). The method was linear over the concentration range 0.5-50 μg/mL. After liquid-liquid extraction of the perfusion samples oxidative biotransformation of salicylate was also investigated by HPLC-MS. The method was linear over the concentration range 0.25-5.0 μg/mL. Two hydroxylated metabolites of salicylic acid (2,5-dihydroxybenzoic acid and 2,3-dihydroxybenzoic acid) were detected and identified. The mean recovery of extraction was 72.4% for 2,3-DHB, 72.5% for 2,5-DHB and 50.1% for salicylic acid, respectively. The methods were successfully applied to investigate jejunal absorption and oxidative metabolism of sodium salicylate in experimental animals. The methods provide analytical background for further metabolic studies of salycilates under modified physiological conditions.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D008297 Male Males
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Mónika Kuzma, and Eszter Nyúl, and Mátyás Mayer, and Emil Fischer, and Pál Perjési
November 1984, Acta pharmacologica et toxicologica,
Mónika Kuzma, and Eszter Nyúl, and Mátyás Mayer, and Emil Fischer, and Pál Perjési
December 1977, Chemical & pharmaceutical bulletin,
Mónika Kuzma, and Eszter Nyúl, and Mátyás Mayer, and Emil Fischer, and Pál Perjési
May 2002, Chemico-biological interactions,
Mónika Kuzma, and Eszter Nyúl, and Mátyás Mayer, and Emil Fischer, and Pál Perjési
January 1994, Pharmaceutical research,
Mónika Kuzma, and Eszter Nyúl, and Mátyás Mayer, and Emil Fischer, and Pál Perjési
January 2015, Journal of pharmaceutical and biomedical analysis,
Mónika Kuzma, and Eszter Nyúl, and Mátyás Mayer, and Emil Fischer, and Pál Perjési
December 1954, The Biochemical journal,
Mónika Kuzma, and Eszter Nyúl, and Mátyás Mayer, and Emil Fischer, and Pál Perjési
November 2014, International journal of pharmaceutics,
Mónika Kuzma, and Eszter Nyúl, and Mátyás Mayer, and Emil Fischer, and Pál Perjési
February 1980, Xenobiotica; the fate of foreign compounds in biological systems,
Mónika Kuzma, and Eszter Nyúl, and Mátyás Mayer, and Emil Fischer, and Pál Perjési
November 1983, Journal of pharmacobio-dynamics,
Mónika Kuzma, and Eszter Nyúl, and Mátyás Mayer, and Emil Fischer, and Pál Perjési
January 1972, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!